{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T12:23:35Z","timestamp":1777897415694,"version":"3.51.4"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003989","name":"Basque Foundation for Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003989","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012818","name":"Community of Madrid","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015496","name":"Center for Networked Biomedical Research on Neurodegenerative Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015496","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011033","name":"State Agency of Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Redox Biology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.redox.2026.104107","type":"journal-article","created":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T20:42:05Z","timestamp":1772484125000},"page":"104107","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Hexaraphane as a potential therapeutic strategy for tauopathies"],"prefix":"10.1016","volume":"92","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7876-0638","authenticated-orcid":false,"given":"\u00c1ngel Juan","family":"Garc\u00eda-Yag\u00fce","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Carnicero-Senabre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1ngel","family":"N\u00fa\u00f1ez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaela","family":"Cipriani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Estibaliz","family":"Capetillo-Zarate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maribel","family":"Escoll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isao","family":"Okunishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana I.","family":"Rojo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Cuadrado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5800","key":"10.1016\/j.redox.2026.104107_bib1","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1126\/science.1132814","article-title":"A century of alzheimer's disease","volume":"314","author":"Goedert","year":"2006","journal-title":"Science"},{"issue":"77","key":"10.1016\/j.redox.2026.104107_bib2","doi-asserted-by":"crossref","first-page":"77sr1","DOI":"10.1126\/scitranslmed.3002369","article-title":"Alzheimer's disease: the challenge of the second century","volume":"3","author":"Holtzman","year":"2011","journal-title":"Sci. Transl. Med."},{"issue":"Suppl 1","key":"10.1016\/j.redox.2026.104107_bib3","first-page":"S141","article-title":"GSK3 and tau: two convergence points in Alzheimer's disease","volume":"33","author":"Hernandez","year":"2013","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.redox.2026.104107_bib4","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3389\/fnmol.2014.00065","article-title":"Physiological and pathological phosphorylation of tau by Cdk5","volume":"7","author":"Kimura","year":"2014","journal-title":"Front. Mol. Neurosci."},{"issue":"4","key":"10.1016\/j.redox.2026.104107_bib5","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.3233\/JAD-2010-1317","article-title":"PP2A regulates tau phosphorylation directly and also indirectly via activating GSK-3beta","volume":"19","author":"Qian","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.redox.2026.104107_bib6","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.freeradbiomed.2025.07.051","article-title":"Dual targeting of Keap1 and Gsk-3 by hexaraphane in the regulation of transcription factor Nrf2","volume":"239","author":"Garcia-Yague","year":"2025","journal-title":"Free Radic. Biol. Med."},{"issue":"4","key":"10.1016\/j.redox.2026.104107_bib7","doi-asserted-by":"crossref","first-page":"267","DOI":"10.4162\/nrp.2013.7.4.267","article-title":"Anti-obesity effects of hot water extract from Wasabi (Wasabia japonica Matsum.) leaves in mice fed high-fat diets","volume":"7","author":"Yamasaki","year":"2013","journal-title":"Nutr. Res. Prac."},{"issue":"2","key":"10.1016\/j.redox.2026.104107_bib8","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.cdp.2004.07.010","article-title":"Selective sensitivity to wasabi-derived 6-(methylsulfinyl)hexyl isothiocyanate of human breast cancer and melanoma cell lines studied in vitro","volume":"29","author":"Nomura","year":"2005","journal-title":"Cancer Detect. Prev."},{"issue":"7","key":"10.1016\/j.redox.2026.104107_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19072083","article-title":"Protective effects of 6-(Methylsulfinyl)hexyl isothiocyanate on Abeta(1-42)-Induced cognitive deficit, oxidative stress, inflammation, and apoptosis in mice","volume":"19","author":"Morroni","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.redox.2026.104107_bib10","article-title":"Molecular mechanisms underlying anti-inflammatory actions of 6-(Methylsulfinyl)hexyl isothiocyanate derived from wasabi (Wasabia japonica)","volume":"2012","author":"Uto","year":"2012","journal-title":"Adv. Pharmacol. Sci."},{"issue":"3","key":"10.1016\/j.redox.2026.104107_bib11","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1254\/jphs.10257FP","article-title":"Glutathione biosynthesis via activation of the nuclear factor E2-related factor 2 (Nrf2)--antioxidant-response element (ARE) pathway is essential for neuroprotective effects of sulforaphane and 6-(methylsulfinyl) hexyl isothiocyanate","volume":"115","author":"Mizuno","year":"2011","journal-title":"J. Pharmacol. Sci."},{"issue":"22","key":"10.1016\/j.redox.2026.104107_bib12","doi-asserted-by":"crossref","first-page":"11975","DOI":"10.1021\/jf2032439","article-title":"Dynamics of Nrf2 and Keap1 in ARE-mediated NQO1 expression by wasabi 6-(methylsulfinyl)hexyl isothiocyanate","volume":"59","author":"Hou","year":"2011","journal-title":"J. Agric. Food Chem."},{"issue":"6","key":"10.1016\/j.redox.2026.104107_bib13","doi-asserted-by":"crossref","DOI":"10.1128\/MCB.00467-19","article-title":"Nrf2 suppresses oxidative stress and inflammation in app Knock-In Alzheimer's Disease model mice","volume":"40","author":"Uruno","year":"2020","journal-title":"Mol. Cell Biol."},{"issue":"2","key":"10.1016\/j.redox.2026.104107_bib14","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1365-2443.2010.01473.x","article-title":"Molecular mechanisms of the Keap1-Nrf2 pathway in stress response and cancer evolution","volume":"16","author":"Taguchi","year":"2011","journal-title":"Genes Cells"},{"issue":"4","key":"10.1016\/j.redox.2026.104107_bib15","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.tibs.2014.02.002","article-title":"The Nrf2 regulatory network provides an interface between redox and intermediary metabolism","volume":"39","author":"Hayes","year":"2014","journal-title":"Trends Biochem. Sci."},{"issue":"1","key":"10.1016\/j.redox.2026.104107_bib16","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1101\/gad.13.1.76","article-title":"Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain","volume":"13","author":"Itoh","year":"1999","journal-title":"Genes Dev."},{"issue":"1","key":"10.1016\/j.redox.2026.104107_bib17","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1128\/MCB.26.1.221-229.2006","article-title":"Oxidative and electrophilic stresses activate Nrf2 through inhibition of ubiquitination activity of Keap1","volume":"26","author":"Kobayashi","year":"2006","journal-title":"Mol. Cell Biol."},{"issue":"2","key":"10.1016\/j.redox.2026.104107_bib18","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1128\/MCB.00868-15","article-title":"Characterizations of three major cysteine sensors of Keap1 in stress response","volume":"36","author":"Saito","year":"2016","journal-title":"Mol. Cell Biol."},{"issue":"3","key":"10.1016\/j.redox.2026.104107_bib19","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jcmgh.2017.11.016","article-title":"Experimental nonalcoholic steatohepatitis and liver fibrosis are ameliorated by pharmacologic activation of Nrf2 (NF-E2 p45-Related factor 2)","volume":"5","author":"Sharma","year":"2018","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.redox.2026.104107_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.122261","article-title":"Omaveloxolone ameliorates cognitive dysfunction in APP\/PS1 mice by stabilizing the STAT3 pathway","volume":"335","author":"Cui","year":"2023","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.redox.2026.104107_bib21","doi-asserted-by":"crossref","first-page":"680","DOI":"10.4049\/jimmunol.181.1.680","article-title":"The transcription factor Nrf2 is a therapeutic target against brain inflammation","volume":"181","author":"Innamorato","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.redox.2026.104107_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2025.103853","article-title":"NRF2 deficiency is associated with synaptic alterations and ether-linked phospholipid imbalance in the hippocampus","volume":"86","author":"Carnicero-Senabre","year":"2025","journal-title":"Redox Biol."},{"issue":"3","key":"10.1016\/j.redox.2026.104107_bib23","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/glia.10274","article-title":"High-yield isolation of murine microglia by mild trypsinization","volume":"44","author":"Saura","year":"2003","journal-title":"Glia"},{"key":"10.1016\/j.redox.2026.104107_bib24","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.redox.2018.07.006","article-title":"Deficiency in the transcription factor NRF2 worsens inflammatory parameters in a mouse model with combined tauopathy and amyloidopathy","volume":"18","author":"Rojo","year":"2018","journal-title":"Redox Biol."},{"key":"10.1016\/j.redox.2026.104107_bib25","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.redox.2017.07.006","article-title":"NRF2 deficiency replicates transcriptomic changes in Alzheimer's patients and worsens APP and TAU pathology","volume":"13","author":"Rojo","year":"2017","journal-title":"Redox Biol."},{"issue":"2","key":"10.1016\/j.redox.2026.104107_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1001259","article-title":"Astrocytes mediate in vivo cholinergic-induced synaptic plasticity","volume":"10","author":"Navarrete","year":"2012","journal-title":"PLoS Biol."},{"issue":"7","key":"10.1016\/j.redox.2026.104107_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0219167","article-title":"A three-criteria performance score for rats exercising on a running treadmill","volume":"14","author":"Rios-Kristjansson","year":"2019","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.redox.2026.104107_bib28","doi-asserted-by":"crossref","first-page":"H675","DOI":"10.1152\/ajpheart.00867.2011","article-title":"Cytoskeletal role in protection of the failing heart by beta-adrenergic blockade","volume":"302","author":"Cheng","year":"2012","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"5","key":"10.1016\/j.redox.2026.104107_bib29","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/glia.20947","article-title":"Nrf2 regulates microglial dynamics and neuroinflammation in experimental Parkinson's disease","volume":"58","author":"Rojo","year":"2010","journal-title":"Glia"},{"issue":"10","key":"10.1016\/j.redox.2026.104107_bib30","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1080\/15548627.2016.1208889","article-title":"Transcription factor NFE2L2\/NRF2 is a regulator of macroautophagy genes","volume":"12","author":"Pajares","year":"2016","journal-title":"Autophagy"},{"key":"10.1016\/j.redox.2026.104107_bib31","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1146\/annurev.publhealth.23.100901.140546","article-title":"The importance of the normality assumption in large public health data sets","volume":"23","author":"Lumley","year":"2002","journal-title":"Annu. Rev. Publ. Health"},{"issue":"5","key":"10.1016\/j.redox.2026.104107_bib32","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s10459-010-9222-y","article-title":"Likert scales, levels of measurement and the \"laws\" of statistics","volume":"15","author":"Norman","year":"2010","journal-title":"Adv. Health Sci. Educ. Theory Pract."},{"issue":"3","key":"10.1016\/j.redox.2026.104107_bib33","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/hbm.20112","article-title":"Effects of long-term practice and task complexity in musicians and nonmusicians performing simple and complex motor tasks: implications for cortical motor organization","volume":"25","author":"Meister","year":"2005","journal-title":"Hum. Brain Mapp."},{"issue":"31","key":"10.1016\/j.redox.2026.104107_bib34","doi-asserted-by":"crossref","first-page":"7919","DOI":"10.1523\/JNEUROSCI.0784-08.2008","article-title":"Diverse mechanisms underlie glycinergic feedback transmission onto rod bipolar cells in rat retina","volume":"28","author":"Chavez","year":"2008","journal-title":"J. Neurosci."},{"issue":"10","key":"10.1016\/j.redox.2026.104107_bib35","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1093\/jnen\/nlz073","article-title":"Tau phosphorylation and aggregation in the developing human brain","volume":"78","author":"Hefti","year":"2019","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"3","key":"10.1016\/j.redox.2026.104107_bib36","doi-asserted-by":"crossref","first-page":"4671","DOI":"10.3390\/ijms15034671","article-title":"Tau protein modifications and interactions: their role in function and dysfunction","volume":"15","author":"Mietelska-Porowska","year":"2014","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.redox.2026.104107_bib37","doi-asserted-by":"crossref","first-page":"6697","DOI":"10.1007\/s12035-021-02558-9","article-title":"alpha-Synuclein induces the GSK-3-Mediated phosphorylation and degradation of NURR1 and loss of Dopaminergic hallmarks","volume":"58","author":"Garcia-Yague","year":"2021","journal-title":"Mol. Neurobiol."},{"issue":"18","key":"10.1016\/j.redox.2026.104107_bib38","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1089\/ars.2014.5843","article-title":"The PTEN\/NRF2 axis promotes human carcinogenesis","volume":"21","author":"Rojo","year":"2014","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.redox.2026.104107_bib39","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1146\/annurev.bi.58.070189.002321","article-title":"The structure and regulation of protein phosphatases","volume":"58","author":"Cohen","year":"1989","journal-title":"Annu. Rev. Biochem."},{"issue":"4","key":"10.1016\/j.redox.2026.104107_bib40","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/0306-4522(94)90400-6","article-title":"Dephosphorylation of alzheimer's disease abnormally phosphorylated tau by protein phosphatase-2A","volume":"61","author":"Gong","year":"1994","journal-title":"Neuroscience"},{"issue":"3","key":"10.1016\/j.redox.2026.104107_bib41","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/j.1471-4159.1993.tb03603.x","article-title":"Phosphoprotein phosphatase activities in Alzheimer disease brain","volume":"61","author":"Gong","year":"1993","journal-title":"J. Neurochem."},{"issue":"8","key":"10.1016\/j.redox.2026.104107_bib42","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1111\/j.1460-9568.2005.04391.x","article-title":"Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation","volume":"22","author":"Liu","year":"2005","journal-title":"Eur. J. Neurosci."},{"issue":"1","key":"10.1016\/j.redox.2026.104107_bib43","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0014-4827(91)90523-W","article-title":"The protein phosphatase inhibitor okadaic acid induces morphological changes typical of apoptosis in mammalian cells","volume":"195","author":"Boe","year":"1991","journal-title":"Exp. Cell Res."},{"issue":"6","key":"10.1016\/j.redox.2026.104107_bib44","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/S0002-9440(10)62486-8","article-title":"Up-regulation of inhibitors of protein phosphatase-2A in Alzheimer's disease","volume":"166","author":"Tanimukai","year":"2005","journal-title":"Am. J. Pathol."},{"issue":"16","key":"10.1016\/j.redox.2026.104107_bib45","doi-asserted-by":"crossref","first-page":"10513","DOI":"10.1074\/jbc.M709852200","article-title":"I1PP2A affects tau phosphorylation via association with the catalytic subunit of protein phosphatase 2A","volume":"283","author":"Chen","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"23","key":"10.1016\/j.redox.2026.104107_bib46","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.2174\/092986708785909111","article-title":"Hyperphosphorylation of microtubule-associated protein tau: a promising therapeutic target for Alzheimer disease","volume":"15","author":"Gong","year":"2008","journal-title":"Curr. Med. Chem."},{"issue":"4","key":"10.1016\/j.redox.2026.104107_bib47","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12040786","article-title":"Evaluating p-tau217 and p-tau231 as biomarkers for early diagnosis and differentiation of Alzheimer's Disease: a narrative review","volume":"12","author":"Jarek","year":"2024","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.redox.2026.104107_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008784","article-title":"Microglia acquire distinct activation profiles depending on the degree of alpha-synuclein neuropathology in a rAAV based model of Parkinson's disease","volume":"5","author":"Sanchez-Guajardo","year":"2010","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.redox.2026.104107_bib49","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1089\/ars.2015.6549","article-title":"Repurposing the NRF2 activator dimethyl fumarate as therapy against synucleinopathy in Parkinson's Disease","volume":"25","author":"Lastres-Becker","year":"2016","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.redox.2026.104107_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neurobiolaging.2015.10.016","article-title":"Sulforaphane exerts its anti-inflammatory effect against amyloid-beta peptide via STAT-1 dephosphorylation and activation of Nrf2\/HO-1 cascade in human THP-1 macrophages","volume":"38","author":"An","year":"2016","journal-title":"Neurobiol. Aging"},{"issue":"6","key":"10.1016\/j.redox.2026.104107_bib51","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1124\/mol.107.042499","article-title":"Kavalactones protect neural cells against amyloid beta peptide-induced neurotoxicity via extracellular signal-regulated kinase 1\/2-dependent nuclear factor erythroid 2-related factor 2 activation","volume":"73","author":"Wruck","year":"2008","journal-title":"Mol. Pharmacol."},{"issue":"Pt 1","key":"10.1016\/j.redox.2026.104107_bib52","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1093\/brain\/awt323","article-title":"Fractalkine activates NRF2\/NFE2L2 and heme oxygenase 1 to restrain tauopathy-induced microgliosis","volume":"137","author":"Lastres-Becker","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.redox.2026.104107_bib53","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.freeradbiomed.2024.11.048","article-title":"NRF2 activation by 6-MSITC increases the generation of neuroprotective, soluble alpha amyloid precursor protein by inducing the metalloprotease gene ADAM17","volume":"227","author":"Carnicero-Senabre","year":"2025","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.redox.2026.104107_bib54","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.redox.2017.10.010","article-title":"Pharmacological targeting of GSK-3 and NRF2 provides neuroprotection in a preclinical model of tauopathy","volume":"14","author":"Cuadrado","year":"2018","journal-title":"Redox Biol."},{"issue":"5","key":"10.1016\/j.redox.2026.104107_bib55","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0968-0004(99)01375-4","article-title":"Regulation of protein kinase cascades by protein phosphatase 2A","volume":"24","author":"Millward","year":"1999","journal-title":"Trends Biochem. Sci."},{"issue":"2","key":"10.1016\/j.redox.2026.104107_bib56","doi-asserted-by":"crossref","first-page":"749","DOI":"10.3233\/JAD-151208","article-title":"Selenoprotein S reduces endoplasmic reticulum stress-induced phosphorylation of tau: potential role in selenate mitigation of tau pathology","volume":"55","author":"Rueli","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.redox.2026.104107_bib57","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2020.570223","article-title":"Chronic sodium selenate treatment restores deficits in cognition and synaptic plasticity in a murine model of tauopathy","volume":"13","author":"Ahmed","year":"2020","journal-title":"Front. Mol. Neurosci."},{"issue":"1","key":"10.1016\/j.redox.2026.104107_bib58","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3233\/JAD-160544","article-title":"A phase IIa randomized control trial of VEL015 (Sodium selenate) in mild-moderate Alzheimer's Disease","volume":"54","author":"Malpas","year":"2016","journal-title":"J. Alzheimers Dis."},{"issue":"6","key":"10.1016\/j.redox.2026.104107_bib59","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1172\/JCI89548","article-title":"Activation of tumor suppressor protein PP2A inhibits KRAS-driven tumor growth","volume":"127","author":"Sangodkar","year":"2017","journal-title":"J. Clin. Investig."},{"issue":"3","key":"10.1016\/j.redox.2026.104107_bib60","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.cell.2020.03.038","article-title":"Selective PP2A enhancement through biased Heterotrimer stabilization","volume":"181","author":"Leonard","year":"2020","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.redox.2026.104107_bib61","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12935-023-03193-1","article-title":"Altering phosphorylation in cancer through PP2A modifiers","volume":"24","author":"Johnson","year":"2024","journal-title":"Cancer Cell Int."},{"issue":"50","key":"10.1016\/j.redox.2026.104107_bib62","doi-asserted-by":"crossref","first-page":"21830","DOI":"10.1073\/pnas.0912793107","article-title":"Biguanide metformin acts on tau phosphorylation via mTOR\/protein phosphatase 2A (PP2A) signaling","volume":"107","author":"Kickstein","year":"2010","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.1016\/j.redox.2026.104107_bib63","doi-asserted-by":"crossref","first-page":"836","DOI":"10.12659\/MSM.912059","article-title":"Metformin inhibit lung cancer cell growth and invasion in vitro as well as tumor Formation in vivo partially by activating PP2A","volume":"25","author":"Zhou","year":"2019","journal-title":"Med. Sci. Monit."},{"issue":"8","key":"10.1016\/j.redox.2026.104107_bib64","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.jocn.2010.04.020","article-title":"Sodium selenate specifically activates PP2A phosphatase, dephosphorylates tau and reverses memory deficits in an Alzheimer's disease model","volume":"17","author":"Corcoran","year":"2010","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.redox.2026.104107_bib65","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.neuropharm.2016.05.001","article-title":"Sodium selenate, a protein phosphatase 2A activator, mitigates hyperphosphorylated tau and improves repeated mild traumatic brain injury outcomes","volume":"108","author":"Tan","year":"2016","journal-title":"Neuropharmacology"},{"issue":"31","key":"10.1016\/j.redox.2026.104107_bib66","doi-asserted-by":"crossref","first-page":"13888","DOI":"10.1073\/pnas.1009038107","article-title":"Sodium selenate mitigates tau pathology, neurodegeneration, and functional deficits in Alzheimer's disease models","volume":"107","author":"van Eersel","year":"2010","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"17","key":"10.1016\/j.redox.2026.104107_bib67","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1016\/j.febslet.2011.07.020","article-title":"Mechanism of inhibition of PP2A activity and abnormal hyperphosphorylation of tau by I2(PP2A)\/SET","volume":"585","author":"Arnaud","year":"2011","journal-title":"FEBS Lett."},{"issue":"8","key":"10.1016\/j.redox.2026.104107_bib68","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1158\/0008-5472.CAN-17-0123","article-title":"Small-Molecule activators of protein phosphatase 2A for the treatment of castration-resistant prostate cancer","volume":"78","author":"McClinch","year":"2018","journal-title":"Cancer Res."},{"issue":"14","key":"10.1016\/j.redox.2026.104107_bib69","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2022110611","article-title":"Chemogenetic profiling reveals PP2A-independent cytotoxicity of proposed PP2A activators iHAP1 and DT-061","volume":"41","author":"Vit","year":"2022","journal-title":"EMBO J."},{"key":"10.1016\/j.redox.2026.104107_bib70","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/151979","article-title":"Tau hyperphosphorylation and oxidative stress, a critical vicious circle in neurodegenerative tauopathies?","volume":"2015","author":"Alavi Naini","year":"2015","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.redox.2026.104107_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2025.149590","article-title":"Advancing Alzheimer's disease therapy through engineered exosomal macromolecules","volume":"1855","author":"Jain","year":"2025","journal-title":"Brain Res."},{"key":"10.1016\/j.redox.2026.104107_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2024.173943","article-title":"Discovery of novel fatty acid amide hydrolase (FAAH) inhibitors as anti-alzheimer agents via in-silico-based drug design, virtual screening, molecular docking, molecular dynamics simulation, DFT, and non-clinical studies","volume":"247","author":"Jain","year":"2025","journal-title":"Pharmacol. Biochem. Behav."}],"container-title":["Redox Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231726001059?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231726001059?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T08:58:12Z","timestamp":1777625892000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213231726001059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":72,"alternative-id":["S2213231726001059"],"URL":"https:\/\/doi.org\/10.1016\/j.redox.2026.104107","relation":{},"ISSN":["2213-2317"],"issn-type":[{"value":"2213-2317","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hexaraphane as a potential therapeutic strategy for tauopathies","name":"articletitle","label":"Article Title"},{"value":"Redox Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.redox.2026.104107","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104107"}}